Appendix C: Cost of PEP regimens

Post-Exposure Prophylaxis after non-occupational and occupational exposure to HIV 

Australian National Guidelines (Third Edition)

Last Updated: June 2023

Further Information

Appendix C: Cost of PEP regimens

Cost of PEP regimens

Regimen	Approximate cost / 28-day course (AUD $)
Tenofovir disoproxil (TD)/emtricitabine (FTC)	40
TD + lamivudine 300 mg	80
TD/FTC with raltegravir^b	600
TD/FTC with dolutegravir	670
Tenofovir alafenamide (TAF)/FTC	700
TAF/FTC with raltegravir	1270
TAF/FTC with dolutegravir	1330
TAF/FTC/cobicistat/elvitegravir	960

^a costs correct as at 22 September 2022 ^b cost unchanged irrespective of dosage or whether taken daily or twice daily

Endorsed By

These guidelines are pending endorsement by the Blood Borne Viruses and Sexually Transmitted Infections Standing Committee (BBVSS).

Funded By: The Australian Government Department of Health
Disclaimer: Whilst the Australian Department of Health provides financial assistance to ASHM Health, the material contained in this resource produced by us should not be taken to represent the views of the Australian Department of Health.

The content of this resource is the sole responsibility of ASHM Health.

We acknowledge that ASHM Health offices are located on the land of the Gadigal peoples of the Eora Nation (Sydney Office) and the Turrbal and Jagera/Yuggera peoples (Brisbane Office) who are the Traditional Owners of the lands where both offices are situated. We pay our respects to Elders past and present.